Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.020
+0.095 (3.25%)
At close: May 12, 2025, 4:00 PM
3.000
-0.020 (-0.66%)
After-hours: May 12, 2025, 7:48 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $382.51 million as of May 12, 2025. Its market cap has decreased by -48.34% in one year.
Market Cap
382.51M
Enterprise Value
132.79M
1-Year Change
-48.34%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $382.51M, a decrease of -83.08%. That is a compound annual growth rate of -37.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 370.48M | -55.68% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.25B |
| Johnson & Johnson | 372.36B |
| UnitedHealth Group | 344.72B |
| AbbVie | 338.78B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.82B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |